Medical-device company Invenio Imaging is at the forefront of a technological breakthrough. They are developing a system that allows surgeons to instantly evaluate tissue biopsies in the operating room. With the help of AI, surgeons can gain insights in just three minutes, a process that…
The American Medical Association (AMA) has conducted research to understand the landscape and decision-making process behind cost and commercial payer…
Citing several limitations inherent to the terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), an international multisociety panel…
The FDA has given its approval for the subcutaneous administration of Takeda Pharmaceuticals’ Entyvio as a maintenance therapy for adult…
Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has expanded its collaboration with GRAIL, LLC,…
Patients with confirmed nonerosive gastroesophageal reflux disease (GERD) are not at greater…
Thought Leadership
This insightful article discusses the limitations and potential of generative artificial intelligence,…
Physician’s Weekly recently had a discussion with Dr. Satish SC Rao, an…
In this Medscape’s InDiscussion series on irritable bowel syndrome (IBS), Dr. Lin…
ARTIFICIAL INTELLIGENCE (AI)
Medical-device company Invenio Imaging is at the forefront of a technological breakthrough. They are developing a system that allows surgeons…
Tech & Innovation
Exponential Tech
Medical-device company Invenio Imaging is at the forefront of a technological breakthrough.…